Relative effects of exercise training and alendronate treatment on skeletal muscle function of ovariectomized rats

Menopause

Volumn 14, Issue 3, 2007, Pages 528-534

  Widrick, Jeffrey J ^a   Fuchs, Robyn ^a   Maddalozzo, Gianni F ^a   Marley, Kevin ^a   Snow, Christine ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Bisphosphonates; Endurance training; Exercise; Muscle fatigue

Indexed keywords

ALENDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

ANIMAL; ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; ENDURANCE; FAST MUSCLE FIBER; FEMALE; METABOLISM; OVARIECTOMY; RAT; REPRODUCIBILITY; SKELETAL MUSCLE; SLOW MUSCLE FIBER; WISTAR RAT;

ALENDRONATE; ANIMALS; BONE DENSITY CONSERVATION AGENTS; FEMALE; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; OVARIECTOMY; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL ENDURANCE; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS;

EID: 34447268206     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/01.gme.0000227861.35226.fa     Document Type: Article

References (36)

1. Office of Disease Prevention and Health Promotion. Healthy People 2010: Understanding and Improving Health. Rockville, MD: US Department of Health and Human Services, 2000.
2. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 1998;280:2077-2082.
3. Melton LJ III, Alothman KI, Khosla S, et al. Fracture risk following bilateral orchiectomy. J Urol 2003;169:1747-1750.
4. Proctor DN, Melton LJ, Khosla S, et al. Relative influence of physical activity, muscle mass and strength on bone density. Osteoporos Int 2000;11:944-952.
5. Ribot C, Tremollieres F, Pouilles JM, et al. Risk factors for hip fracture. MEDOS study: results of the Toulouse Centre. Bone 1993;14(Suppl 1):S77-S80.
6. Aloia JF, McGowan DM, Vaswani AN, Ross P, Cohn SH. Relationship of menopause to skeletal and muscle mass. Am J Clin Nutr 1991;53:1378-1383.
7. Maddalozzo GF, Snow CM. High intensity resistance training: effects on bone in older men and women. Calcif Tissue Int 2000;66:399-404.
8. Wallace BA, Cumming RG. Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women. Calcif Tissue Int 2000;67:10-18.
9. Joakimsen RM, Magnus JH, Fonnebo V. Physical activity and predisposition for hip fractures: a review. Osteoporos Int 1997;7:503-513.
10. Liberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 1995;333:1437-1443.
11. Karpf DB, Shapiro DR, Seeman E, et al. Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups. JAMA 1997;277:1159-1164.
12. Walsh MC, Hunter GR, Livingstone MB. Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density. Osteoporos Int 2006;17:61-67.
13. Montpetit K, Plotkin H, Rauch F, et al. Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta. Pediatrics 2003;111:601-603.
14. Ylitalo R, Kalliovalkama J, Wu X, et al. Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro. Pharmacol Toxicol 1998;83:125-131.
15. Paspaliaris V, Leaver DD. Clodronate inhibits contraction and prevents the action of L-type calcium channel antagonists in vascular smooth muscle. J Bone Miner Res 1991;6:835-841.
16. Uusi-Rasi K, Kannus P, Cheng S, et al. Effect of alendronate and exercise on bone and physical performance of postmenopausal women: a randomized controlled trial. Bone 2003;33:132-143.
17. Fuchs RK, Shea M, Durski SL, Winters-Stone KM, Widrick J, Snow CM. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats. Bone (In press).
18. Fitts RH, Metzger JM, Riley DA, Unsworth BR. Models of disuse: a comparison of hindlimb suspension and immobilization. J Appl Physiol 1986;60:1947-1953.
19. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
20. Barnard RJ, Edgerton VR, Peter JB. Effect of exercise on skeletal muscle. II. Contractile properties. J Appl Physiol 1970;28:767-770.
21. Fitts RH, Holloszy JO. Contractile properties of rat soleus muscle: effects of training and fatigue. Am J Physiol Cell Physiol 1977;233:C86-C91.
22. Fisher JS, Hasser EM, Brown M. Effects of ovariectomy and hindlimb unloading on skeletal muscle. J Appl Physiol 1998;85:1316-1321.
23. Jansson JO, Ekberg S, Isaksson OG, Eden S. Influence of gonadal steroids on age- and sex-related secretory patterns of growth hormone in the rat. Endocrinology 1984;114:1287-1294.
24. Kalu DN, Arjmandi BH, Liu CC, Salih MA, Birnbaum RS. Effects of ovariectomy and estrogen on the serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3. Bone Miner 1994;25:135-148.
25. Borski RJ, Tsai W, DeMott-Friberg R, Barkan AL. Regulation of somatic growth and the somatotropic axis by gonadal steroids: primary effect on insulin-like growth factor I gene expression and secretion. Endocrinology 1996;137:3253-3259.
26. Andersen NB, Andreassen TT, Orskov H, Oxlund H. Growth hormone and mild exercise in combination increases markedly muscle mass and tetanic tension in old rats. Eur J Endocrinol 2000;143:409-418.
27. Edwards RHT, Hill DK, Jones DA, Merton PA. Fatigue of long duration in human skeletal muscle after exercise. J Physiol 1977;272:769-778.
28. Melton LJ III, Riggs BL. Epidemiology of age-related fractures. In: Avioli LV, ed. The Osteoporotic Syndrome. New York, NY: Grune & Stratton, 1983:45-72.
29. Petrofsky JS, Burse RL, Lind AR. Comparison of physiological responses of women and men to isometric exercise. J Appl Physiol 1975;38:863-868.
30. Phillips SK, Rook KM, Siddle NC, Bruce SA, Woledge RC. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci 1993;84:95-98.
31. Skelton DA, Phillips SK, Bruce SA, Naylor CH, Woledge RC. Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausal women. Clin Sci 1999;96:357-364.
32. Sipilä S, Taaffe DR, Cheng S, Puolakka J, Toivanen J, Suominen H. Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin Sci 2001;101:147-157.
33. Armstrong AL, Oborne J, Coupland CAC, MacPherson MB, Bassy EJ, Wallace WA. Effects of hormone replacement therapy on muscle performance and balance in post-menopausal women. Clin Sci 1996;91:685-690.
34. Kohrt WM, Snead DB, Slatopolsky E, Birge SJ Jr. Additive effects of weight-bearing exercise and estrogen on bone mineral density in older women. J Bone Miner Res 1995;10:1303-1311.
35. Widrick JJ, Maddalozzo GF, Lewis D, et al. Morphological and functional characteristics of skeletal muscle fibers from hormone-replaced and nonreplaced postmenopausal women. J Gerontol A Biol Sci Med Sci 2003;58:3-10.
36. Maddalozzo GF, Cardinal BJ, Li F, Snow CM. The association between hormone therapy use and changes in strength and body composition in early postmenopausal women. Menopause 2004;11:438-446.